共 167 条
- [1] Goossens H(2007)Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries Clin Infect Dis 44 1091-1095
- [2] Ferech M(2005)Antimicrobial safety: focus on fluoroquinolones Clin Infect Dis 15 S144-S157
- [3] Coenen S(2003)Fluoroquinolones and the risk for methicillin-resistant Emerg Infect Dis 9 1415-1422
- [4] Stephens P(2008) in hospitalized patients Clin Infect Dis 46 S19-S31
- [5] Owens RC(2008)Antimicrobial-associated risk factors for Antimicrob Agents Chemother 52 3795-3800
- [6] Ambrose PG(2007) infection Am J Infect Control 35 S165-S193
- [7] Weber SG(2007)Fluoroquinolones enhances the mutation frequency for meropenem-selected carbapenem resistance in Clin Infect Dis 44 159-177
- [8] Gold HS(2004), but use of the high-potency drug doripenem inhibits mutant formation J Antimicrob Chemother 53 853-859
- [9] Hooper DC(2006)Management of multidrug-resistant organisms in health care settings, 2006 Clin Infect Dis 42 778-784
- [10] Karchmer AW(2006)Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Infect Control Hosp Epidemiol 27 155-169